BTAI

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

BioXcel Therapeutics Inc

NASDAQ | BTAI

2.20

USD

$0.00

(

0.00%

)

At Close (As of Oct 21, 2025)

$43.60M

Market Cap

-

P/E Ratio

-11.9

EPS

$13.28

52 Week High

$1.17

52 Week Low

HEALTHCARE

Sector

BTAI Chart

Recent Chart
Price Action

BTAI Technicals

Tags:

BTAI Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $123K
Total Revenue $2.3M
Cost Of Revenue $2.1M
Costof Goods And Services Sold $2.1M
Operating Income -$67M
Selling General And Administrative $33M
Research And Development $30M
Operating Expenses $67M
Investment Income Net -
Net Interest Income -$13M
Interest Income $2.6M
Interest Expense $15M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $309K
Income Before Tax -$60M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$60M
Comprehensive Income Net Of Tax -
Ebit -$44M
Ebitda -$44M
Net Income -$60M

Revenue & Profitability

Earnings Performance

BTAI Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $38M
Total Current Assets $37M
Cash And Cash Equivalents At Carrying Value $30M
Cash And Short Term Investments $30M
Inventory $679K
Current Net Receivables $131K
Total Non Current Assets $944K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $6.7M
Other Non Current Assets -
Total Liabilities $131M
Total Current Liabilities $22M
Current Accounts Payable $16M
Deferred Revenue -
Current Debt -
Short Term Debt $748K
Total Non Current Liabilities $109M
Capital Lease Obligations $439K
Long Term Debt $103M
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $103M
Other Current Liabilities $5.4M
Other Non Current Liabilities -
Total Shareholder Equity -$93M
Treasury Stock -
Retained Earnings -$650M
Common Stock $49K
Common Stock Shares Outstanding $2.5M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$72M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $309K
Capital Expenditures $0
Change In Receivables -
Change In Inventory $1.3M
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $37M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$60M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $123K
Total Revenue $2.3M
Cost Of Revenue $2.1M
Costof Goods And Services Sold $2.1M
Operating Income -$67M
Selling General And Administrative $33M
Research And Development $30M
Operating Expenses $67M
Investment Income Net -
Net Interest Income -$13M
Interest Income $2.6M
Interest Expense $15M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $309K
Income Before Tax -$60M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$60M
Comprehensive Income Net Of Tax -
Ebit -$44M
Ebitda -$44M
Net Income -$60M

BTAI News

BTAI Profile

BioXcel Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

BioXcel Therapeutics Inc. is an innovative clinical-phase biopharmaceutical company based in New Haven, Connecticut, specializing in harnessing artificial intelligence to revolutionize drug discovery and development, particularly in the fields of neuroscience and immuno-oncology. The company boasts a promising pipeline of therapies designed to address significant unmet medical needs, emphasizing its commitment to transforming patient care through novel therapeutics. By integrating state-of-the-art AI technologies with extensive scientific expertise, BioXcel is strategically positioned to lead advancements in an evolving healthcare landscape, making it an attractive consideration for institutional investors.

BYND
+146.25%
$3.62
VHAI
0.00%
$0.00
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
NVDA
-0.81%
$181.16
GDXD
+28.69%
$0.86
AIRE
+61.36%
$0.72
BURU
-14.84%
$0.28
BITF
-9.83%
$4.49
PLUG
-8.23%
$3.12
ADAP
-17.62%
$0.04
T
-0.19%
$26.05
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
DNN
-7.16%
$2.72
BTG
-9.12%
$5.18
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
DVLT
+4.54%
$2.52
CLF
-17.24%
$13.39
AXDX
-61.36%
$0.03
IBIO
+24.30%
$1.11
GSIT
-16.26%
$10.86
RIG
+0.60%
$3.31
TLRY
-5.73%
$1.48
NVTS
-12.10%
$15.03
RXRX
-8.53%
$6.11
ETHD
-0.80%
$3.72
SOFI
+0.24%
$28.75
ABEV
-2.20%
$2.22
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
AMZN
+2.56%
$222.03
EOSE
+8.59%
$16.30
GRAB
-1.23%
$5.60
GOOGL
-2.37%
$250.46
AMD
-1.05%
$238.03
AAPL
+0.20%
$262.77
LAES
-5.86%
$6.10
QUBT
-7.40%
$16.00
ACHR
-4.75%
$11.41
IONZ
+1.48%
$4.11
GM
+14.86%
$66.62
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
BTBT
-8.29%
$3.87
VALE
-1.14%
$11.27
BBD
-2.36%
$3.30
IREN
-6.79%
$55.19
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
GPUS
-7.57%
$0.36
DCGO
+24.16%
$1.49
MARA
-3.18%
$20.07
HAL
+11.58%
$25.24
RMBL
+60.50%
$3.21
CJET
-20.45%
$0.08
AAL
+1.47%
$12.35
DFLI
-3.96%
$1.21
ADD
-25.47%
$0.05
CLSK
-7.99%
$18.77
NOK
-2.27%
$5.58
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.62%
$51.85
AMC
+4.33%
$2.89
KO
+4.06%
$71.22
SNAP
+1.55%
$7.85
PBR
-1.11%
$11.56
ONDS
-7.46%
$7.19
SMR
-13.20%
$38.36
VZ
-1.22%
$40.29
HBAN
+0.63%
$15.94
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
WTO
+2.93%
$0.06
SMCI
-0.39%
$54.82
GGB
-1.17%
$3.37
EPWK
-8.71%
$0.07
WLGS
-5.57%
$0.04
PM
-3.83%
$152.00
RIVN
+0.91%
$13.20
GOOG
-2.20%
$251.34
PLTR
-0.04%
$181.51
BAC
-0.99%
$51.52
APLD
-9.35%
$32.54
RGTZ
+15.11%
$15.61
ETWO
0.00%
$3.30
BULL
-2.96%
$11.14
IONQ
-0.73%
$59.50
MSN
+59.31%
$0.76
BYND
+146.25%
$3.62
VHAI
0.00%
$0.00
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
NVDA
-0.81%
$181.16
GDXD
+28.69%
$0.86
AIRE
+61.36%
$0.72
BURU
-14.84%
$0.28
BITF
-9.83%
$4.49
PLUG
-8.23%
$3.12
ADAP
-17.62%
$0.04
T
-0.19%
$26.05
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
DNN
-7.16%
$2.72
BTG
-9.12%
$5.18
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
DVLT
+4.54%
$2.52
CLF
-17.24%
$13.39
AXDX
-61.36%
$0.03
IBIO
+24.30%
$1.11
GSIT
-16.26%
$10.86
RIG
+0.60%
$3.31
TLRY
-5.73%
$1.48
NVTS
-12.10%
$15.03
RXRX
-8.53%
$6.11
ETHD
-0.80%
$3.72
SOFI
+0.24%
$28.75
ABEV
-2.20%
$2.22
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
AMZN
+2.56%
$222.03
EOSE
+8.59%
$16.30
GRAB
-1.23%
$5.60
GOOGL
-2.37%
$250.46
AMD
-1.05%
$238.03
AAPL
+0.20%
$262.77
LAES
-5.86%
$6.10
QUBT
-7.40%
$16.00
ACHR
-4.75%
$11.41
IONZ
+1.48%
$4.11
GM
+14.86%
$66.62
SOUN
-4.35%
$18.23
RR
+1.25%
$5.63
BTBT
-8.29%
$3.87
VALE
-1.14%
$11.27
BBD
-2.36%
$3.30
IREN
-6.79%
$55.19
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
GPUS
-7.57%
$0.36
DCGO
+24.16%
$1.49
MARA
-3.18%
$20.07
HAL
+11.58%
$25.24
RMBL
+60.50%
$3.21
CJET
-20.45%
$0.08
AAL
+1.47%
$12.35
DFLI
-3.96%
$1.21
ADD
-25.47%
$0.05
CLSK
-7.99%
$18.77
NOK
-2.27%
$5.58
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.62%
$51.85
AMC
+4.33%
$2.89
KO
+4.06%
$71.22
SNAP
+1.55%
$7.85
PBR
-1.11%
$11.56
ONDS
-7.46%
$7.19
SMR
-13.20%
$38.36
VZ
-1.22%
$40.29
HBAN
+0.63%
$15.94
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
WTO
+2.93%
$0.06
SMCI
-0.39%
$54.82
GGB
-1.17%
$3.37
EPWK
-8.71%
$0.07
WLGS
-5.57%
$0.04
PM
-3.83%
$152.00
RIVN
+0.91%
$13.20
GOOG
-2.20%
$251.34
PLTR
-0.04%
$181.51
BAC
-0.99%
$51.52
APLD
-9.35%
$32.54
RGTZ
+15.11%
$15.61
ETWO
0.00%
$3.30
BULL
-2.96%
$11.14
IONQ
-0.73%
$59.50
MSN
+59.31%
$0.76
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.